๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Small Cell Lung Cancer Extensive Stage
Clinical trial register · China

Small Cell Lung Cancer Extensive Stage Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 4 Guangzhou 3 Hangzhou 2 Fuzhou 2 Chengdu 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai4 Guangzhou3 Hangzhou2 Fuzhou2 Chengdu2
All 15 locations
Target enrolment
to

Small Cell Lung Cancer Extensive Stage trials in China

13 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
NCT07227597Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC
Phase 1/2
170
Beijing, Fuzhou, Guangzhou, Jiangmen, Nanchang, Shanghai, Chengdu, Hangzhou
2026-01-29
Recruiting
A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06954246Small Cell Lung Cancer Extensive Stage
Qilu Pharmaceutical Co., Ltd.
Phase 3
450
Shanghai
2025-06-04
Recruiting
Phase I Clinical Study of ฮฑ-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
NCT06348797Small Cell Lung Cancer Extensive Stage
Sichuan University
Phase 1
30
Chengdu
2025-04-03
Not yet open
Tislelizumab in Combination with Chemotherapy ยฑ Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.
NCT06851819Small Cell Lung Cancer Extensive Stage
Hebei Medical University Fourth Hospital
Phase 2
64
Shijiazhuang
2025-03-01
Recruiting
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
NCT06739928Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease
Phase 2
120
Guangzhou
2025-01-01
Recruiting
Liposomal Irinotecan and Apatinib in ES-SCLC
NCT06749691Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2024-12-28
Not yet open
Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer
NCT06648200Small Cell Lung Cancer Extensive Stage, Small Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
100
Shanghai
2024-11-01
Recruiting
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
NCT06429696Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University
Phase 2
40
Guangzhou
2024-07-14
Recruiting
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
NCT05745350Small Cell Lung Cancer Extensive Stage
Xiaorong Dong
Phase 2
45
Wuhan
2024-03-07
Recruiting
IN10018 Combination Therapy in Treatment-naรฏve ES-SCLC
NCT06030258Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd.
Phase 1/2
120
Jinan, Tianjin, Zhengzhou
2023-10-30
Recruiting
Molecular Analysis and Treatment Options of SCLC
NCT05945745Small-cell Lung Cancer, Small Cell Lung Cancer, Combined Type, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage
Shanghai Chest Hospital
Observational
500
Shanghai
2016-01-01
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/small-cell-lung-cancer-extensive-stage

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies listing the condition Small Cell Lung Cancer Extensive Stage.

How many Small Cell Lung Cancer Extensive Stage trials are recruiting in China?

10 of the 13 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Small Cell Lung Cancer Extensive Stage), 13 studies
PhaseStudiesRecruitingShare
Phase 28561.5%
Phase 1/22215.4%
Observational117.7%
Phase 1117.7%
Phase 3117.7%

Most active sponsors

Lead sponsors with the most studies (Small Cell Lung Cancer Extensive Stage)
Lead sponsorStudiesRecruiting
Sichuan University22
Fujian Cancer Hospital10
Guangzhou Institute of Respiratory Disease11
Hebei Medical University Fourth Hospital10
InxMed (Shanghai) Co., Ltd.11
Merck Sharp & Dohme LLC11
Nanfang Hospital, Southern Medical University11
Qilu Pharmaceutical Co., Ltd.11
Second Affiliated Hospital, Zhejiang University, School of Medicine11
Shanghai Chest Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.